Improving bone healing in older adults using new drug delivery methods
Rejuvenating aged bone regeneration by innovative nanomaterials-mediated drug delivery
This study is looking at new ways to help older adults heal their bones better by using special drugs that reduce inflammation and encourage bone growth, making it easier for their bodies to recover from injuries or conditions affecting their bones.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-10823351 on NIH RePORTER |
What this research studies
This research focuses on enhancing bone regeneration in older adults by utilizing innovative drug delivery systems that target the body's own healing mechanisms. The approach involves using small molecules that can reduce inflammation and promote bone growth, particularly in aged bones that struggle to heal due to factors like iron accumulation. By developing a scaffold that mimics natural bone and allows for sustained release of these drugs, the study aims to improve the effectiveness of treatments for bone disorders in seniors.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults, particularly those experiencing bone disorders or slow healing due to aging.
Not a fit: Patients who are younger than 21 or do not have any bone regeneration issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for bone regeneration in older adults, potentially reducing the need for invasive surgeries.
How similar studies have performed: Previous research has shown promise in using similar drug delivery methods to enhance tissue regeneration, indicating a potential for success in this innovative approach.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Sun, Hongli — University of Iowa
- Study coordinator: Sun, Hongli
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.